Amyloidosis

"Amyloidosis" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure, which enables searching at various levels of specificity.

MeSH information

Definition | Details | More General Concepts | Related Concepts | More Specific Concepts

A group of sporadic, familial and/or inherited, degenerative, and infectious disease processes, linked by the common theme of abnormal protein folding and deposition of AMYLOID. As the amyloid deposits enlarge they displace normal tissue structures, causing disruption of function. Various signs and symptoms depend on the location and size of the deposits.

Descriptor ID	D000686
MeSH Number(s)	C18.452.845.500
Concept/Terms	Amyloidosis Amyloidosis Amyloidoses

Below are MeSH descriptors whose meaning is more general than "Amyloidosis".

Diseases [C]
Nutritional and Metabolic Diseases [C18]
Metabolic Diseases [C18.452]
Proteostasis Deficiencies [C18.452.845]
Amyloidosis [C18.452.845.500]

Below are MeSH descriptors whose meaning is related to "Amyloidosis".

Below are MeSH descriptors whose meaning is more specific than "Amyloidosis".

publications

Timeline | Most Recent

This graph shows the total number of publications written about "Amyloidosis" by people in this website by year, and whether "Amyloidosis" was a major or minor topic of these publications.

Bar chart showing 49 publications over 25 distinct years, with a maximum of 5 publications in 2022

To see the data from this visualization as text, click here.

Year	Major Topic	Minor Topic	Total
1996	1	0	1
1997	1	0	1
1998	1	1	2
1999	1	0	1
2000	1	1	2
2003	1	1	2
2004	1	0	1
2005	0	1	1
2006	2	0	2
2007	2	1	3
2008	0	1	1
2010	1	1	2
2011	1	1	2
2012	1	0	1
2013	1	2	3
2014	1	0	1
2015	1	0	1
2016	2	1	3
2018	1	0	1
2019	3	0	3
2020	1	0	1
2021	4	0	4
2022	5	0	5
2024	3	1	4
2025	1	0	1

Below are the most recent publications written about "Amyloidosis" by people in Profiles.

Ahmad S, Ahsan MJ, Newlun M, Sand M, Rmilah AA, Yousaf A, Shabbir MA, Malik SA, Goldsweig AM. Outcomes of aortic stenosis in patients with cardiac amyloidosis: A systematic review and meta-analysis. Cardiovasc Revasc Med. 2025 Apr; 73:98-106.

View in: PubMed
Anand S, O'Neill-Dee M, Sanchorawala V, Verma A. Light-chain (AL) amyloidosis for nephrologists-treatment standard. Nephrol Dial Transplant. 2024 Dec 20; 40(1):34-47.

View in: PubMed
Wang X, Campbell B, Bodogai M, McDevitt RA, Patrikeev A, Gusev F, Ragonnaud E, Kumaraswami K, Shirenova S, Vardy K, Alameh MG, Weissman D, Ishikawa-Ankerhold H, Okun E, Rogaev E, Biragyn A. CD8+ T cells exacerbate AD-like symptoms in mouse model of amyloidosis. Brain Behav Immun. 2024 Nov; 122:444-455.

View in: PubMed
Cheng R, Kittleson MM, Wechalekar AD, Alvarez-Cardona J, Mitchell JD, Scarlatelli Macedo AV, Dutra JPP, Campbell CM, Liu JE, Landau HJ, Davis MK, Morrissey S, Casselli S, Lousada I, Seabra-Garcez JD, Szor RS, Ganatra S, Trachtenberg B, Maurer MS, Stockerl-Goldstein K, Lenihan D. Moving towards establishing centres of excellence in cardiac amyloidosis: an International Cardio-Oncology Society statement. Heart. 2024 May 23; 110(12):823-830.

View in: PubMed
Anand SK, Sanchorawala V, Verma A. Systemic Amyloidosis and Kidney Transplantation: An Update. Semin Nephrol. 2024 Jan; 44(1):151496.

View in: PubMed
Mir T, Uddin M, Ulbeh TM, Perveiz E, Lohia P, Sattar Y, Abohashem S, Ullah W, Maganti K, Qureshi WT, Lakis N. Clinical Outcomes of Aortic Stenosis in Amyloidosis: A United States National Cohort Study. Heart Lung Circ. 2024 Apr; 33(4):443-449.

View in: PubMed
Rowin EJ, Ruberg FL, Das G, Higgins D, Lipe WC, Bokhari N, Dehn M, Maron BJ, Maron MS. Identification of Transthyretin Cardiac Amyloidosis Among Patients Previously Diagnosed With Hypertrophic Cardiomyopathy. Circ Cardiovasc Imaging. 2022 12; 15(12):e014938.

View in: PubMed
Prokaeva T, Klimtchuk ES, Feschenko P, Spencer B, Cui H, Burks EJ, Aslebagh R, Muneeruddin K, Shaffer SA, Varghese E, Berk JL, Connors LH. An additive destabilising effect of compound T60I and V122I substitutions in ATTRv amyloidosis. Amyloid. 2023 Jun; 30(2):141-152.

View in: PubMed
D?zel E, Ziegler G, Berron D, Maass A, Sch?tze H, Cardenas-Blanco A, Glanz W, Metzger C, Dobisch L, Reuter M, Spottke A, Brosseron F, Fliessbach K, Heneka MT, Laske C, Peters O, Priller J, Spruth EJ, Ramirez A, Speck O, Schneider A, Teipel S, Kilimann I, Jens W, Schott BH, Preis L, Gref D, Maier F, Munk MH, Roy N, Ballarini T, Yakupov R, Haynes JD, Dechent P, Scheffler K, Wagner M, Jessen F. Amyloid pathology but not APOE e4 status is permissive for tau-related hippocampal dysfunction. Brain. 2022 05 24; 145(4):1473-1485.

View in: PubMed
Aslam W, Najafi AG, Lamb CR. Severe tracheobronchial amyloidosis. Am J Med Sci. 2022 09; 364(3):366-368.

View in: PubMed

People

Explore

Similar Concepts

Top Journals